Thomas Lindsay
Director/Board Member at GENEDRIVE PLC
Net worth: 11 200 $ as of 2024-03-30
Thomas Lindsay active positions
| Companies | Position | Start | End |
|---|---|---|---|
| GENEDRIVE PLC | Director/Board Member | 2018-04-08 | - |
| TRINITY BIOTECH PLC | Director/Board Member | 2022-10-25 | - |
| Independent Dir/Board Member | 2022-10-25 | - | |
| Sales & Marketing | - | - |
Career history of Thomas Lindsay
Former positions of Thomas Lindsay
| Companies | Position | Start | End |
|---|---|---|---|
Abbott Rapid Diagnostics ULC
 Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The private company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Corporate Officer/Principal | - | 2016-12-31 |
| NIGERIAN-GERMAN CHEMICALS PLC | Director/Board Member | 2011-07-21 | - |
Training of Thomas Lindsay
| Glasgow Caledonian University | Undergraduate Degree |
Statistics
International
| United Kingdom | 3 |
| Ireland | 2 |
| Nigeria | 2 |
Operational
| Director/Board Member | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| TRINITY BIOTECH PLC | Health Technology |
| GENEDRIVE PLC | Health Technology |
| NIGERIAN-GERMAN CHEMICALS PLC | Health Technology |
| Private companies | 1 |
|---|---|
Abbott Rapid Diagnostics ULC
Abbott Rapid Diagnostics ULC Medical DistributorsDistribution Services Part of Abbott Laboratories, Abbott Rapid Diagnostics ULC is a world leader in rapid point of care (POC) solutions. The private company's focus is on creating patient-centered diagnostic tests that can provide invaluable answers to doctors, healthcare professionals, and nurses when and where they are needed most. The company is based in Ottawa, Canada. The Canadian company provides innovative diagnostic tests for critical areas such as cardiology, infectious disease, and toxicology. | Distribution Services |
- Stock Market
- Insiders
- Thomas Lindsay
- Experience
